EWA
PDSB icon

EP Wealth Advisors’s PDS Biotechnology PDSB Stock Holding History

EP Wealth Advisors’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,207
Closed -$29.9K – 1200
2024
Q2 		$29.9K Hold
10,207
– – ﹤0.01% 843
2024
Q1 		$40.4K Hold
10,207
– – ﹤0.01% 820
2023
Q4 		$50.7K Hold
10,207
– – ﹤0.01% 802
2023
Q3 		$51.5K Buy
+10,207
New +$55.9K ﹤0.01% 737
2023
Q2 		– Sell
-38,337
Closed -$2.91M – 711
2023
Q1 		$2.91M Buy
38,337
+28,130
+276% +$230K 0.05% 194
2022
Q4 		$135K Buy
10,207
+207
+2% +$1.46K ﹤0.01% 578
2022
Q3 		$30K Buy
+10,000
New +$42.4K ﹤0.01% 334

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EP Wealth Advisors's PDSB Position: Q3 2024 in Review

EP Wealth Advisors sold out of PDS Biotechnology (PDSB) in Q3 2024, closing a stake of 10,207 shares — an estimated $29.9K sold.

EP Wealth Advisors first reported a position in PDSB in Q3 2022 and held it in 7 quarters. The position peaked at $2.91M in Q1 2023. 57 funds tracked by Wall St. Rank hold PDSB as of Q3 2024.

  • EP Wealth Advisors reported no remaining PDS Biotechnology position as of Q3 2024 after selling out during the quarter.
  • EP Wealth Advisors sold 10,207 PDS Biotechnology shares in Q3 2024, an estimated $29.9K.
  • EP Wealth Advisors first reported a position in PDS Biotechnology in Q3 2022 and held it in 7 quarters.
  • EP Wealth Advisors's PDS Biotechnology position peaked at $2.91M in Q1 2023.
  • 57 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2024.

Based on EP Wealth Advisors's 13F filing for Q3 2024, filed 15 Nov 2024.